Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157331893> ?p ?o ?g. }
- W2157331893 endingPage "2020" @default.
- W2157331893 startingPage "2020" @default.
- W2157331893 abstract "Androstenedione, a precursor to testosterone, is marketed to increase blood testosterone concentrations as a natural alternative to anabolic steroid use. However, whether androstenedione actually increases blood testosterone levels or produces anabolic androgenic effects is not known.To determine if short- and long-term oral androstenedione supplementation in men increases serum testosterone levels and skeletal muscle fiber size and strength and to examine its effect on blood lipids and markers of liver function.Eight-week randomized controlled trial conducted between February and June 1998.Thirty healthy, normotestosterogenic men (aged 19-29 years) not taking any nutritional supplements or androgenic-anabolic steroids or engaged in resistance training.Twenty subjects performed 8 weeks of whole-body resistance training. During weeks 1, 2, 4, 5, 7, and 8, the men were randomized to either androstenedione, 300 mg/d (n = 10), or placebo (n = 10). The effect of a single 100-mg androstenedione dose on serum testosterone and estrogen concentrations was determined in 10 men.Changes in serum testosterone and estrogen concentrations, muscle strength, muscle fiber cross-sectional area, body composition, blood lipids, and liver transaminase activities based on assessments before and after short- and long-term androstenedione administration.Serum free and total testosterone concentrations were not affected by short- or long-term androstenedione administration. Serum estradiol concentration (mean [SEM]) was higher (P<.05) in the androstenedione group after 2 (310 [20] pmol/L), 5 (300 [30] pmol/L), and 8 (280 [20] pmol/L) weeks compared with presupplementation values (220 [20] pmol/L). The serum estrone concentration was significantly higher (P<.05) after 2 (153 [12] pmol/L) and 5 (142 [15] pmol/L) weeks of androstenedione supplementation compared with baseline (106 [11] pmol/L). Knee extension strength increased significantly (P<.05) and similarly in the placebo (770 [55] N vs 1095 [52] N) and androstenedione (717 [46] N vs 1024 [57] N) groups. The increase of the mean cross-sectional area of type 2 muscle fibers was also similar in androstenedione (4703 [471] vs 5307 [604] mm2; P<.05) and placebo (5271 [485] vs 5728 [451] mm2; P<.05) groups. The significant (P<.05) increases in lean body mass and decreases in fat mass were also not different in the androstenedione and placebo groups. In the androstenedione group, the serum high-density lipoprotein cholesterol concentration was reduced after 2 weeks (1.09 [0.08] mmol/L [42 (3) mg/dL] vs 0.96 [0.08] mmol/L [37 (3) mg/dL]; P<.05) and remained low after 5 and 8 weeks of training and supplementation.Androstenedione supplementation does not increase serum testosterone concentrations or enhance skeletal muscle adaptations to resistance training in normotestosterogenic young men and may result in adverse health consequences." @default.
- W2157331893 created "2016-06-24" @default.
- W2157331893 creator A5007576937 @default.
- W2157331893 creator A5030018967 @default.
- W2157331893 creator A5038400761 @default.
- W2157331893 creator A5046731322 @default.
- W2157331893 creator A5059396999 @default.
- W2157331893 creator A5069149772 @default.
- W2157331893 creator A5081304135 @default.
- W2157331893 date "1999-06-02" @default.
- W2157331893 modified "2023-10-16" @default.
- W2157331893 title "Effect of Oral Androstenedione on Serum Testosterone and Adaptations to Resistance Training in Young Men" @default.
- W2157331893 cites W129280754 @default.
- W2157331893 cites W178628951 @default.
- W2157331893 cites W1963813683 @default.
- W2157331893 cites W1965859977 @default.
- W2157331893 cites W1976276194 @default.
- W2157331893 cites W1981350201 @default.
- W2157331893 cites W1982216157 @default.
- W2157331893 cites W1985615435 @default.
- W2157331893 cites W1986394571 @default.
- W2157331893 cites W1988817246 @default.
- W2157331893 cites W1997184570 @default.
- W2157331893 cites W1997549339 @default.
- W2157331893 cites W2001431048 @default.
- W2157331893 cites W2012632792 @default.
- W2157331893 cites W2016427104 @default.
- W2157331893 cites W2026802581 @default.
- W2157331893 cites W2030643536 @default.
- W2157331893 cites W2032716696 @default.
- W2157331893 cites W2038138852 @default.
- W2157331893 cites W2044402174 @default.
- W2157331893 cites W2051718793 @default.
- W2157331893 cites W2053014484 @default.
- W2157331893 cites W2057196832 @default.
- W2157331893 cites W2069587738 @default.
- W2157331893 cites W2077198167 @default.
- W2157331893 cites W2077760013 @default.
- W2157331893 cites W2098531741 @default.
- W2157331893 cites W2102231551 @default.
- W2157331893 cites W2118310760 @default.
- W2157331893 cites W2166229501 @default.
- W2157331893 cites W2326289669 @default.
- W2157331893 cites W2367186945 @default.
- W2157331893 cites W2377682128 @default.
- W2157331893 cites W2419029047 @default.
- W2157331893 cites W2427004753 @default.
- W2157331893 cites W2032742845 @default.
- W2157331893 doi "https://doi.org/10.1001/jama.281.21.2020" @default.
- W2157331893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10359391" @default.
- W2157331893 hasPublicationYear "1999" @default.
- W2157331893 type Work @default.
- W2157331893 sameAs 2157331893 @default.
- W2157331893 citedByCount "209" @default.
- W2157331893 countsByYear W21573318932012 @default.
- W2157331893 countsByYear W21573318932013 @default.
- W2157331893 countsByYear W21573318932014 @default.
- W2157331893 countsByYear W21573318932015 @default.
- W2157331893 countsByYear W21573318932016 @default.
- W2157331893 countsByYear W21573318932017 @default.
- W2157331893 countsByYear W21573318932018 @default.
- W2157331893 countsByYear W21573318932019 @default.
- W2157331893 countsByYear W21573318932020 @default.
- W2157331893 countsByYear W21573318932021 @default.
- W2157331893 countsByYear W21573318932022 @default.
- W2157331893 countsByYear W21573318932023 @default.
- W2157331893 crossrefType "journal-article" @default.
- W2157331893 hasAuthorship W2157331893A5007576937 @default.
- W2157331893 hasAuthorship W2157331893A5030018967 @default.
- W2157331893 hasAuthorship W2157331893A5038400761 @default.
- W2157331893 hasAuthorship W2157331893A5046731322 @default.
- W2157331893 hasAuthorship W2157331893A5059396999 @default.
- W2157331893 hasAuthorship W2157331893A5069149772 @default.
- W2157331893 hasAuthorship W2157331893A5081304135 @default.
- W2157331893 hasBestOaLocation W21573318931 @default.
- W2157331893 hasConcept C1008401 @default.
- W2157331893 hasConcept C120863210 @default.
- W2157331893 hasConcept C126322002 @default.
- W2157331893 hasConcept C134018914 @default.
- W2157331893 hasConcept C142724271 @default.
- W2157331893 hasConcept C147583825 @default.
- W2157331893 hasConcept C204787440 @default.
- W2157331893 hasConcept C27081682 @default.
- W2157331893 hasConcept C2776214593 @default.
- W2157331893 hasConcept C2776683971 @default.
- W2157331893 hasConcept C2777164284 @default.
- W2157331893 hasConcept C2777911890 @default.
- W2157331893 hasConcept C2778656385 @default.
- W2157331893 hasConcept C2779279991 @default.
- W2157331893 hasConcept C71315377 @default.
- W2157331893 hasConcept C71924100 @default.
- W2157331893 hasConceptScore W2157331893C1008401 @default.
- W2157331893 hasConceptScore W2157331893C120863210 @default.
- W2157331893 hasConceptScore W2157331893C126322002 @default.
- W2157331893 hasConceptScore W2157331893C134018914 @default.
- W2157331893 hasConceptScore W2157331893C142724271 @default.
- W2157331893 hasConceptScore W2157331893C147583825 @default.
- W2157331893 hasConceptScore W2157331893C204787440 @default.